Public annual accounts

EPHAMED financials

A multi-period view of the public annual-account figures reported for EPHAMED, with comparable measures and links to available source documents.

Company overview
Registry number

0674631733

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€86,691

-24.2%

EBITDA
€85,965

-24.5%

Total assets
€113,433

-18.8%

Equity
€47,487

+22%

EBITDA margin +99.2% · Equity ratio +41.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€86,691€85,965€113,433€47,487-
202431 Dec 2024€114,322€113,807€139,667€38,917-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report